Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
S01EA05	ALPHANOVA	G	Brimonidine tartrate - 0.15%	0.15%	Drops solution	599,354 L.L
A02BC05	SOLEZOL	G	Esomeprazole - 40mg	40mg	Injectable powder for solution	301,021 L.L
A11DB	3V	G	Vitamin B12 - 200mcg, Vitamin B6 - 200mg, Vitamin B1 - 100mg		Tablet	229,797 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	188,772 L.L
C07AB04	ACEBUTOLOL BIOGARAN	G	Acebutolol HCl - 200mg	200mg	Tablet, coated	464,970 L.L
C09DA03	VIOSTAN PLUS 160/12.5	G	Valsartan - 160mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	668,082 L.L
C10AX09	EZETIMIBE BIOGARAN	G	Ezetimibe - 10mg	10mg	Tablet	1,894,818 L.L
J01DD04	LEBACEF	G	Ceftriaxone - 1g	1g	Injectable sterile powder for solution + lidocaine solvent	508,100 L.L
N02BE01	SUPOFEN	G	Paracetamol - 10mg/ml	10mg/ml	Injectable solution	7,675,286 L.L
N05AH03	APO-OLANZAPINE ODT	G	Olanzapine - 10mg	10mg	Tablet, orally disintegrating	3,628,375 L.L
R03DA04	THEOSOL ELIXIR	G	Théophylline - 25mg/5ml	25mg/5ml	Elixir	312,283 L.L
S01EA05	BGLAU	G	Brimonidine tartrate - 0.2%	0.2%	Drops solution	638,325 L.L
A11DB	MED-PRINCO-B FORT	G	Vitamin B12 - 200mcg, Vitamin B6 - 200mg, Vitamin B1 - 100mg		Tablet, coated	386,515 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	174,553 L.L
C10AX09	EZETRALEX	G	Ezetimibe - 10mg	10mg	Tablet	972,686 L.L
D11AX10	FINJUVE	G	Finasteride - 2.275mg/ml	2.275mg/ml	Spray, solution	6,708,462 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution+diluent	508,100 L.L
J01XX01	FOSFOKEY	G	Fosfomycine (trométamol) - 3g	3g	Granules for solution	399,121 L.L
L01BB05	FLUDARABIN EBEWE	G	Fludarabine Dihydrogenophosphate - 50mg/2ml	50mg/2ml	Injectable solution	3,567,902 L.L
N02BE01	PARANOR	G	Paracetamol - 650mg	650mg	Tablet	162,605 L.L
N05AH03	OLANZAX 10	G	Olanzapine - 10mg	10mg	Tablet, mouth dissolving	2,329,327 L.L
R03DA04	THEODEX	G	Theophylline - 80mg/15ml	80mg/15ml	Elixir	156,142 L.L
S01EA05	BRIMO	G	Brimonidine tartrate - 0.2%	0.2%	Drops solution	658,483 L.L
A11DB	NEUROMED	G	Vitamin B12 - 200mcg, Vitamin B6 - 200mg, Vitamin B1 - 100mg		Tablet, coated	257,250 L.L
B05XA03	ISOTONIC SALINE	G	Sodium chloride - 0.9%	0.9%	Injectable solution	167,780 L.L
C09DA03	ARBITEN PLUS	G	Valsartan - 160mg, Hydrochlorothiazide - 25mg		Tablet	579,196 L.L
C10AX09	XIMACOL	G	Ezetimibe - 10mg	10mg	Tablet	1,894,818 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
J01DD04	LEBACEF	G	Ceftriaxone (sodium) - 1g	1g	Injectable powder for solution	5,793,881 L.L
J01XX01	FOSFOLAG	G	Fosfomycine (trométamol) - 3g	3g	Granules for solution	399,121 L.L